Persistent and pathogen-specific infection risk during long-term survivorship after CD19 chimeric antigen receptor T-cell therapy: an Australian multicentre cohort study

Clinical Microbiology and Infection · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles